Imaging and treatments to stop joint damage after knee injuries
Imaging and therapeutic targeting of tissue crosstalk in the injured knee
This project tries combined imaging and therapies to stop cartilage loss and inflammation after ACL and other knee injuries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11289384 on NIH RePORTER |
What this research studies
From a patient point of view, researchers will look at how dying cartilage cells and inflamed joint lining 'talk' to each other after a knee injury using lab-grown cells, gene-level analysis, and advanced imaging. They will test how blocking both cell death and inflammation together affects that harmful communication in animal models and tissue experiments. The team plans to identify specific molecules involved and try combined treatments that aim to restore normal joint healing. Work will be led at NYU and could guide future human treatments or trials.
Who could benefit from this research
Good fit: People with recent knee injuries such as ACL tears or others at high risk for posttraumatic osteoarthritis would be the most relevant candidates for related future trials.
Not a fit: Patients with long-standing, end-stage osteoarthritis or those without a traumatic knee injury are unlikely to benefit from these specific interventions.
Why it matters
Potential benefit: If successful, this work could lead to new combined treatments that slow or prevent posttraumatic osteoarthritis and reduce the need for early knee replacement after ACL tears.
How similar studies have performed: Previous attempts to block inflammation or cell death alone have not stopped posttraumatic osteoarthritis, so this combined-targeting approach is relatively novel though supported by the investigators' preliminary lab and animal data.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Ruiz Garzon, Maria Amparo — New York University School of Medicine
- Study coordinator: Ruiz Garzon, Maria Amparo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.